<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/48BEC8B8-65B6-4B35-883C-14C635CCEF48"><gtr:id>48BEC8B8-65B6-4B35-883C-14C635CCEF48</gtr:id><gtr:name>Arvia Technology Limited</gtr:name><gtr:address><gtr:line1>THE HEATH BUSINESS AND TECHNICAL PARK , THE HEATH BUSINESS &amp; TECHNICAL PARK</gtr:line1><gtr:city>RUNCORN</gtr:city><gtr:postCode>WA7 4EB</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48BEC8B8-65B6-4B35-883C-14C635CCEF48" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>48BEC8B8-65B6-4B35-883C-14C635CCEF48</gtr:id><gtr:name>Arvia Technology Limited</gtr:name><gtr:address><gtr:line1>THE HEATH BUSINESS AND TECHNICAL PARK , THE HEATH BUSINESS &amp; TECHNICAL PARK</gtr:line1><gtr:city>RUNCORN</gtr:city><gtr:postCode>WA7 4EB</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>46558.0</gtr:offerGrant><gtr:projectCost>68771.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57864C53-6CE7-457C-9640-7201B24F67D8" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>57864C53-6CE7-457C-9640-7201B24F67D8</gtr:id><gtr:name>National Nuclear Laboratory Limited</gtr:name><gtr:address><gtr:line1>Chadwick House
Warrington Road
Birchwood Park</gtr:line1><gtr:city>Warrington</gtr:city><gtr:postCode>WA3 6AE</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>28330.0</gtr:offerGrant><gtr:projectCost>49947.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/ADEAD59E-821A-4006-874D-88562C9B3379"><gtr:id>ADEAD59E-821A-4006-874D-88562C9B3379</gtr:id><gtr:firstName>Liz</gtr:firstName><gtr:surname>Freeman</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=131035"><gtr:id>32AA0276-7349-4CD4-A670-756590C80D23</gtr:id><gtr:title>Development of Arvia?'s second generation electrochemical technology for the treatment of high-alpha contaminated organic wastes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>131035</gtr:grantReference><gtr:abstractText>The joint advancement of Arvia?'s second generation, newly patented organic destruction technology from a technology readiness level of 2/3 to 6/7 by testing it in the National Nuclear Laboratory's Central Laboratory on high-alpha contaminated organic wastes, for which current treatment options are suboptimal or non-existent. Recently Arvia?, a multi-award winning SME, has demonstrated the oxidation of low and intermediate level waste radioactive oil at a Magnox Ltd. site. Commercial opportunities in the treatment of high-alpha contaminated organic wastes have driven this further innovation of Arvia?'s technology. Arvia? and NNL have access to expertise and facilities that will fully support the project objectives to design, build and test the technology and to evaluate its potential to be taken forward into an industrial product. An anticipated end user, Sellafield Ltd., has expressed written support of and commitment to the project.</gtr:abstractText><gtr:fund><gtr:end>2014-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2013-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>74888</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">131035</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>